Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. J. Scheffel
Efficacy of Adoptive T-Cell Therapy Is Improved by Treatment With the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-Cell Death
Cancer Research
Cancer Research
Oncology
Related publications
Adoptive T-Cell Therapy for Solid Tumors
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
Differential Ability of T Cell Subsets to Undergo Activation-Induced Cell Death
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Susceptibility to Cell Death Is a Dominant Phenotype: Triggering of Activation-Driven T-Cell Death Independent of the T-Cell Antigen Receptor Complex.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
T Helper Lymphocytes Rescue CTL From Activation-Induced Cell Death
Journal of Immunology
Allergy
Immunology
The Role of TCR Engagement and Activation-Induced Cell Death in Sepsis-Induced T Cell Apoptosis
Journal of Immunology
Allergy
Immunology
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
Frontiers in Immunology
Allergy
Immunology
Adoptive T Cell Therapy: An Overview of Obstacles and Opportunities
Cancer
Cancer Research
Oncology
Activation-Induced Non-Responsiveness (Anergy) Limits CD8 T Cell Responses to Tumors
Seminars in Cancer Biology
Cancer Research
CD8 T Cell Priming in the Presence of IFN- Renders CTLs With Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy
Journal of Immunology
Allergy
Immunology
